Suchergebnisse - "Xu, Dong"

PubPharm (131)

1

Reversal Effect of NVP-BEZ235 on Doxorubicin-Resistance in Burkitt Lymphoma RAJI Cell Line

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2024

von Li, C. | Zhu, X. | Wang, S. | +7

2

PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer

enthalten in: Journal of experimental & clinical cancer research : CR | 2024

von Xu, L. | Xiang, W. | Yang, J. | +8

3

The role of CSE1L silencing in the regulation of proliferation and apoptosis via the AMPK/mTOR signaling pathway in chronic myeloid leukemia

enthalten in: Hematology (Amsterdam, Netherlands) | 2023

von Liu, X. | Wang, Y. | Wang, J. | +3

4

Glucose promotes cell growth and casein synthesis via ATF4/Nrf2-Sestrin2- AMPK-mTORC1 pathway in dairy cow mammary epithelial cells

enthalten in: Animal biotechnology | 2023

von Yu, W. | Guo, J. | Mao, L. | +5

5

The Wnt/β-catenin signaling pathway inhibits osteoporosis by regulating the expression of TERT : an in vivo and in vitro study

enthalten in: Aging | 2023

von Cai, Y. | Sun, H. | Song, X. | +3

6

NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-β2

enthalten in: Cell death & disease | 2023

von Ding, X. | Zhu, X. | Xu, D. | +10

7

HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis

enthalten in: Journal of translational medicine | 2023

von Li, K. | Gong, Q. | Xiang, X. | +10

8

Nono deficiency impedes the proliferation and adhesion of H9c2 cardiomyocytes through Pi3k/Akt signaling pathway

enthalten in: Scientific reports | 2023

von Lei, Y. | Ye, Z. | Wei, Y. | +4

9

Mechanism of Sijunzi Decoction in treatment of Alzheimer's disease based on UPLC-Q-TOF-MS, network pharmacology, and experimental verification

enthalten in: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica | 2023

von Cai, K. | Zheng, Q. | Zhu, X. | +4

10

A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer : A Clinical Trial Protocol

enthalten in: Technology in cancer research & treatment | 2023

von He, J. | Liu, Y. | Liu, C. | +22

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]